The Leadbitter Group has been appointed by the University of Exeter to construct a £2m building for teaching and research to help improve the understanding and treatment of mood disorders. Located behind the Washington Singer building on the university's Streatham campus, the facility consists of a purpose-built treatment centre where clinical trials will be undertaken to evaluate psychological therapies. Professor Ed Watkins of the existing Mood Disorders Centre said "The state-of-the art laboratory facilities will help us study the underlying psychological mechanisms and inform the development of more targeted and effective therapies. The purpose-built treatment centre will allow us to conduct valuable clinical trials to determine which of these new treatments works best, as well as to improve existing treatments."
Leadbitter wins mental health bid
You may also like
Trending Articles
Upcoming event
You may also like
Design & Build
Trust behind Tolworth Hospital redevelopment "hopes to begin rebuilding in the summer"
STEP (Springfield & Tolworth Estate Partnership), an equal partnership between Sir Robert McAlpine Capital Ventures and Kajima Partnerships, is the chosen master developer for the new Tolworth Hospital